Tags

Type your tag names separated by a space and hit enter

Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.
Diabetes Res Clin Pract. 2012 Jun; 96(3):294-305.DR

Abstract

AIM

Despite recent advances in diabetes therapy including the new long- and rapid-insulin analogs, insulin intensification strategies such as basal/bolus or pump therapy and sophisticated methods for insulin titration derived from the principles of functional insulin therapy, many patients fail to reach or maintain target glycosylated hemoglobin (HbA1c) values, putting them at increased risk for vascular complications. Continuous glucose monitoring (CGM) systems represent an important advance in diabetes technology that can facilitate optimal glucose control in type 1 diabetes.

METHOD

This review focuses on the efficacy and safety of CGM systems in diabetes management. The different CGM devices available are also described, as the way to use them and the educational approach to the patient in a step-by-step progression toward optimal glycemic control.

RESULTS

In type 1 diabetes, CGM systems are associated with 0.5-1% reduction in HbA1c without increased risk of hypoglycemia. CGM efficacy correlates with compliance to sensor wear, whatever the patient's age range.

CONCLUSION

Efficacy of CGM systems is now proven but indications, terms of use and educational issues of this new technology still need to be specified.

Authors+Show Affiliations

Caen University Hospital, Department of Endocrinology, Caen F-14000, France.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22209014

Citation

Joubert, M, and Y Reznik. "Personal Continuous Glucose Monitoring (CGM) in Diabetes Management: Review of the Literature and Implementation for Practical Use." Diabetes Research and Clinical Practice, vol. 96, no. 3, 2012, pp. 294-305.
Joubert M, Reznik Y. Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use. Diabetes Res Clin Pract. 2012;96(3):294-305.
Joubert, M., & Reznik, Y. (2012). Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use. Diabetes Research and Clinical Practice, 96(3), 294-305. https://doi.org/10.1016/j.diabres.2011.12.010
Joubert M, Reznik Y. Personal Continuous Glucose Monitoring (CGM) in Diabetes Management: Review of the Literature and Implementation for Practical Use. Diabetes Res Clin Pract. 2012;96(3):294-305. PubMed PMID: 22209014.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use. AU - Joubert,M, AU - Reznik,Y, Y1 - 2011/12/28/ PY - 2011/09/09/received PY - 2011/12/02/revised PY - 2011/12/06/accepted PY - 2012/1/3/entrez PY - 2012/1/3/pubmed PY - 2012/10/20/medline SP - 294 EP - 305 JF - Diabetes research and clinical practice JO - Diabetes Res Clin Pract VL - 96 IS - 3 N2 - AIM: Despite recent advances in diabetes therapy including the new long- and rapid-insulin analogs, insulin intensification strategies such as basal/bolus or pump therapy and sophisticated methods for insulin titration derived from the principles of functional insulin therapy, many patients fail to reach or maintain target glycosylated hemoglobin (HbA1c) values, putting them at increased risk for vascular complications. Continuous glucose monitoring (CGM) systems represent an important advance in diabetes technology that can facilitate optimal glucose control in type 1 diabetes. METHOD: This review focuses on the efficacy and safety of CGM systems in diabetes management. The different CGM devices available are also described, as the way to use them and the educational approach to the patient in a step-by-step progression toward optimal glycemic control. RESULTS: In type 1 diabetes, CGM systems are associated with 0.5-1% reduction in HbA1c without increased risk of hypoglycemia. CGM efficacy correlates with compliance to sensor wear, whatever the patient's age range. CONCLUSION: Efficacy of CGM systems is now proven but indications, terms of use and educational issues of this new technology still need to be specified. SN - 1872-8227 UR - https://www.unboundmedicine.com/medline/citation/22209014/Personal_continuous_glucose_monitoring__CGM__in_diabetes_management:_review_of_the_literature_and_implementation_for_practical_use_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0168-8227(11)00678-4 DB - PRIME DP - Unbound Medicine ER -